Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
Martha Dillon, Antonio R. Lopez, Edward H. Lin, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5059-5059
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 224
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Cancer, metastasis, and the epigenome
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Principles in the Management of Glioblastoma
Domingos Sanchez Roda, Pedro Veiga, Joana Barbosa Melo, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 501-501
Open Access | Times Cited: 15
Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers
Khine Shan, Tauseef Ur Rehman, S. G. Ivanov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 624-624
Open Access | Times Cited: 10
Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics
Manish Kumar
(2025)
Closed Access | Times Cited: 1
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics
Hyun Hee Koh, Eunhyang Park, Hyun Soo Kim
Diagnostics (2022) Vol. 12, Iss. 2, pp. 326-326
Open Access | Times Cited: 37
The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets
Andrea Rocca, Luca Braga, Maria Concetta Volpe, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5306-5306
Open Access | Times Cited: 28
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 6
Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma
Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154947-154947
Closed Access | Times Cited: 15
Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling
Peter Kubatka, Lenka Koklesová, Alena Mazuráková, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 87-113
Open Access | Times Cited: 14
Assessment of Metabolic Imaging Biomarkers for MEK Inhibition Therapy Response in Melanoma
Pradeep Kumar Gupta, Stepan Orlovskiy, Fernando Arias‐Mendoza, et al.
(2024)
Open Access | Times Cited: 5
Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutic
Manish Kumar
Authorea (Authorea) (2025)
Open Access
Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review
Mohammad Aidiel, Maisarah Abdul Mutalib, Rajesh Ramasamy, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 346-346
Open Access
Recent Issues in the Development and Application of Targeted Therapies with Respect to Individual Animal Variability
Natalia Kurhaluk, Halyna Tkachenko
Animals (2025) Vol. 15, Iss. 3, pp. 444-444
Open Access
BRAF V600E in Cancer: Exploring Structural Complexities, Mutation Profiles, and Pathway Dysregulation
Jayhind Bharti, Priyadharshini Gogu, Sarvesh Kumar Pandey, et al.
Experimental Cell Research (2025), pp. 114440-114440
Closed Access
Precision medicine in colorectal cancer: genomics profiling and targeted treatment
Adi Muradi Muhar, Adrian Joshua Velaro, Arya Tjipta Prananda, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cilostazol alleviates imatinib-induced myocardial injury in rats by modulating the TGF-β1/MAPK, SHC/Grb2/SOS signaling pathways and upregulating miRNA-195-5P
Basel A. Abdel‐Wahab, Ehab A. M. El‐Shoura, Saad Misfer Alqahtani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Targeting KRAS-G12C in Lung Cancer: The Emerging Role of PROTACs in Overcoming Resistance
Kumarappan Chidambaram, Arcot Rekha, Ahsas Goyal, et al.
Pathology - Research and Practice (2025), pp. 155954-155954
Closed Access
Regulation of Signaling from the Epidermal Growth Factor Family
Antony W. Burgess
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 39, pp. 7475-7485
Closed Access | Times Cited: 19
Molecular pathways and targeted therapies in head and neck cancers pathogenesis
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The mechanism of activation of MEK1 by B-Raf and KSR1
Ryan Maloney, Mingzhen Zhang, Yonglan Liu, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 16
Detailed curriculum vitae of HER2-targeted therapy
Xiaonan Zhang, Ya Gao, Xi-Ya Zhang, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108417-108417
Closed Access | Times Cited: 10
PAK1 and Therapy Resistance in Melanoma
Julia V. Kichina, Alexei Maslov, Eugene Kandel
Cells (2023) Vol. 12, Iss. 19, pp. 2373-2373
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top